.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
